About

StemCellAtlas is a source-first cell-therapy research and cost-planning guide. It publishes reproducible registry snapshots, regulatory verification steps and indicative commercial price observations with their limitations.

Condition pages link to stored ClinicalTrials.gov queries; cell-label pages link to PubMed, trial registries and regulator guidance so readers can inspect the underlying records.

We work with partner clinic Stem Plus Clinic in Sofia, Bulgaria. Enquiries are forwarded to its medical team; assessment, treatment and any clinical decision are made by the clinic, not by us. Readers should verify current regulatory status and certificates directly.

We believe in transparency: published price ranges of €3,000–€8,000, clear travel costs, and an honest view of what is proven versus still investigational.